LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | CP724714 | 10 | uM | LJP5 | 3 | A07 | 72 | hr | 1209 | 2961 | 4376 | 0.6766 | 0.6203 |
MCF7 | BX-912 | 1.11 | uM | LJP5 | 3 | L21 | 72 | hr | 1209 | 2132 | 4376 | 0.4872 | 0.3573 |
MCF7 | BX-912 | 3.33 | uM | LJP5 | 2 | L20 | 72 | hr | 1209 | 1885 | 4252 | 0.4432 | 0.2771 |
MCF7 | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 1209 | 1687 | 4376 | 0.3855 | 0.1964 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1209 | 2912 | 3980 | 0.7317 | 0.6675 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 1209 | 3368 | 4252 | 0.7920 | 0.7587 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1209 | 3338 | 4376 | 0.7628 | 0.7284 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 1209 | 1581 | 4376 | 0.3613 | 0.1553 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 2 | J06 | 72 | hr | 1209 | 4768 | 4252 | 1.1211 | 1.1301 |
MCF7 | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 1209 | 1652 | 4376 | 0.3775 | 0.1830 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1209 | 2313 | 3980 | 0.5812 | 0.4583 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1209 | 2272 | 4252 | 0.5342 | 0.4156 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1209 | 2190 | 4376 | 0.5004 | 0.3771 |
MCF7 | Seliciclib | 0.37 | uM | LJP5 | 2 | J04 | 72 | hr | 1209 | 3832 | 4252 | 0.9011 | 0.8884 |
MCF7 | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 1209 | 1362 | 4376 | 0.3112 | 0.0661 |
MCF7 | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 1209 | 1346 | 3980 | 0.3382 | 0.0642 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1209 | 1693 | 3980 | 0.4254 | 0.2161 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 1209 | 1686 | 4252 | 0.3965 | 0.2009 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 1209 | 1529 | 4376 | 0.3494 | 0.1347 |
MCF7 | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 1209 | 1475 | 4252 | 0.3468 | 0.1156 |
MCF7 | Seliciclib | 10 | uM | LJP5 | 2 | J01 | 72 | hr | 1209 | 1273 | 4252 | 0.2993 | 0.0286 |
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 1 | B14 | 72 | hr | 1209 | 1439 | 3980 | 0.3616 | 0.1064 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1209 | 1390 | 3980 | 0.3492 | 0.0843 |
MCF7 | AZD-6482 | 0.12 | uM | LJP5 | 2 | I05 | 72 | hr | 1209 | 3945 | 4252 | 0.9276 | 0.9189 |
MCF7 | AZD-6482 | 0.12 | uM | LJP5 | 1 | I05 | 72 | hr | 1209 | 3991 | 3980 | 1.0027 | 1.0032 |